[SFCE harmonization workshops: Neonatal acute myeloid leukemia]

Stéphane Ducassou1, Wadih Abou Chahla2, Nicolas Duployez3

  • 1Service d'hématologie et d'oncologie pédiatrique, CHU de Bordeaux, Bordeaux, France.

Bulletin Du Cancer
|March 19, 2024
PubMed
Summary

Neonatal acute myeloid leukemia (AML) presents unique challenges, often with skin lesions and high white blood cell counts. This review covers true neonatal AML and transient leukemoid reactions, highlighting poor survival rates and treatment complexities.

Related Concept Videos